Colgate-Palmolive Company $CL Shares Purchased by DJE Kapital AG

DJE Kapital AG increased its stake in Colgate-Palmolive Company (NYSE:CLFree Report) by 821.6% in the first quarter, Holdings Channel.com reports. The institutional investor owned 616,276 shares of the company’s stock after purchasing an additional 549,405 shares during the quarter. Colgate-Palmolive comprises about 1.2% of DJE Kapital AG’s holdings, making the stock its 25th largest position. DJE Kapital AG’s holdings in Colgate-Palmolive were worth $52,339,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Glenview Trust Co increased its holdings in Colgate-Palmolive by 4.1% during the 1st quarter. Glenview Trust Co now owns 7,064 shares of the company’s stock worth $602,000 after purchasing an additional 279 shares during the last quarter. Madison Asset Management LLC increased its stake in Colgate-Palmolive by 253.5% during the first quarter. Madison Asset Management LLC now owns 249,020 shares of the company’s stock valued at $21,224,000 after purchasing an additional 178,583 shares during the last quarter. Puzo Michael J acquired a new stake in Colgate-Palmolive during the first quarter worth about $265,000. Cassaday & Co Wealth Management LLC boosted its stake in Colgate-Palmolive by 5.1% in the first quarter. Cassaday & Co Wealth Management LLC now owns 4,264 shares of the company’s stock valued at $363,000 after acquiring an additional 208 shares during the period. Finally, AlTi Global Inc. boosted its stake in Colgate-Palmolive by 1.3% in the first quarter. AlTi Global Inc. now owns 17,778 shares of the company’s stock valued at $1,515,000 after acquiring an additional 227 shares during the period. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

CL has been the topic of a number of research reports. Bank of America dropped their price target on Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating on the stock in a research report on Friday, April 10th. Sanford C. Bernstein initiated coverage on Colgate-Palmolive in a research report on Thursday, June 11th. They issued a “market perform” rating and a $96.00 target price on the stock. Piper Sandler raised their target price on Colgate-Palmolive from $92.00 to $96.00 and gave the company an “overweight” rating in a research note on Thursday, July 9th. Royal Bank Of Canada reissued an “outperform” rating and set a $102.00 price target on shares of Colgate-Palmolive in a report on Monday, May 4th. Finally, Wall Street Zen lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Sunday, March 29th. Twelve analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $97.41.

Get Our Latest Report on CL

Colgate-Palmolive Trading Down 1.1%

NYSE:CL opened at $91.93 on Tuesday. The stock has a market cap of $73.56 billion, a price-to-earnings ratio of 35.77, a PEG ratio of 4.90 and a beta of 0.33. The company has a debt-to-equity ratio of 16.33, a quick ratio of 0.67 and a current ratio of 1.02. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $99.33. The business has a fifty day moving average of $90.56 and a 200-day moving average of $88.69.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its quarterly earnings results on Friday, May 1st. The company reported $0.97 EPS for the quarter, topping analysts’ consensus estimates of $0.94 by $0.03. The company had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.22 billion. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. Colgate-Palmolive’s revenue was up 8.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.91 EPS. Equities analysts predict that Colgate-Palmolive Company will post 3.81 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Monday, July 20th will be issued a dividend of $0.53 per share. The ex-dividend date of this dividend is Monday, July 20th. This represents a $2.12 annualized dividend and a yield of 2.3%. Colgate-Palmolive’s payout ratio is presently 82.49%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

Read More

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.